IFP Advisors, Inc - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 119 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,133
-76.2%
1,975
-50.0%
0.00%
Q2 2023$8,967
+37.1%
3,950
+96.3%
0.00%
Q1 2023$6,539
+81637.5%
2,012
-0.4%
0.00%
Q4 2022$8
-99.9%
2,020
-0.3%
0.00%
Q3 2022$8,0000.0%2,0270.0%0.00%
Q2 2022$8,000
-50.0%
2,027
-50.4%
0.00%
Q1 2022$16,000
+166.7%
4,083
+98.6%
0.00%
Q4 2021$6,000
-33.3%
2,056
-0.3%
0.00%
Q3 2021$9,000
+12.5%
2,062
-4.4%
0.00%
Q2 2021$8,000
+33.3%
2,157
+16.8%
0.00%
Q1 2021$6,000
+50.0%
1,846
+53.6%
0.00%
Q4 2020$4,000
+100.0%
1,202
+9.8%
0.00%
Q3 2020$2,0000.0%1,0950.0%0.00%
Q2 2020$2,0000.0%1,0950.0%0.00%
Q1 2020$2,0001,0950.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$1,0000.0%5000.0%0.00%
Q4 2018$1,0005000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders